Standout Papers

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and ... 2001 2026 2009 2017 5.3k
  1. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (2001)
    Barry M. Brenner, Mark E. Cooper et al. New England Journal of Medicine
  2. Mechanisms of Diabetic Complications (2013)
    Josephine M. Forbes, Mark E. Cooper Physiological Reviews
  3. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease (2009)
    Marc A. Pfeffer, Emmanuel A. Burdmann et al. New England Journal of Medicine
  4. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2013)
    Steven E. Kahn, Mark E. Cooper et al. The Lancet
  5. Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes (2008)
    Josephine M. Forbes, Melinda T. Coughlan et al. Diabetes
  6. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia (2008)
    Assam El‐Osta, Daniella Brasacchio et al. The Journal of Experimental Medicine
  7. The Role of Advanced Glycation End Products in Progression and Complications of Diabetes (2008)
    Su‐Yen Goh, Mark E. Cooper The Journal of Clinical Endocrinology & Metabolism
  8. Diabetic kidney disease (2015)
    Merlin C. Thomas, Michael Brownlee et al. Nature Reviews Disease Primers
  9. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL (2004)
    Dick de Zeeuw, Giuseppe Remuzzi et al. Kidney International
  10. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk (2018)
    Julio Rosenstock, Vlado Perkovic et al. JAMA
  11. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes (2009)
    Toshiharu Ninomiya, Vlado Perkovic et al. Journal of the American Society of Nephrology
  12. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy (2004)
    Dick de Zeeuw, Giuseppe Remuzzi et al. Circulation
  13. Reduced Bone Mass in Daughters of Women with Osteoporosis (1989)
    Ego Seeman, John L. Hopper et al. New England Journal of Medicine
  14. Diabetes and Kidney Disease: Role of Oxidative Stress (2016)
    Jay C. Jha, Bryna S.M. Chow et al. Antioxidants and Redox Signaling
  15. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease (2015)
    Merlin C. Thomas, Mark E. Cooper et al. Nature Reviews Nephrology
  16. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy (2015)
    George L. Bakris, Rajiv Agarwal et al. JAMA

Immediate Impact

9 from Science/Nature 87 standout
Sub-graph 1 of 19

Citing Papers

Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
3 intermediate papers

Works of Mark E. Cooper being referenced

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
2008 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Mark E. Cooper 17386 12906 12490 506 47.5k
Peter Rossing 22306 10797 10480 737 39.4k
Christoph Wanner 17206 13557 8088 706 44.5k
Eberhard Ritz 9208 19039 13530 926 43.6k
Barry M. Brenner 8398 14779 12872 290 38.8k
William E. Mitch 5887 11097 7778 298 36.5k
Ann Marie Schmidt 11514 3327 3568 390 48.7k
James R. Sowers 14251 3247 15126 681 41.2k
George L. Bakris 24604 11719 34537 836 66.0k
Hiddo J.L. Heerspink 15519 10487 6359 583 27.7k
Elizabeth Selvin 11516 4733 7730 507 31.6k

All Works

Loading papers...

Rankless by CCL
2026